Wang C, Yeung C, Enriquez A, et al. - Researchers conducted the first prospective study of patients with serologically-confirmed LC investigating the long-term outcomes of these patients.

• Seven patients (mean age 31.3 years, 86% male) with LC presented with second-degree type I/II or third-degree AVB and underwent treatment involving the standard protocol including 10 days of intravenous ceftriaxone followed by oral antibiotics for a total course of 3 weeks.

• Malaise (71%), presyncope (43%), syncope (29%), palpitations (57%), and dyspnea (43%) were the presenting symptoms in these patients.

• During long-term follow-up, all patients were asymptomatic, in sinus rhythm, and showed no conduction abnormalities.